Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 10.84
(0.18%)
CNY 10.84
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 87.53 Million | 301.62 Million | 185.62 Million | 236.66 Million | 162.57 Million | 176.06 Million |
| Net Income | 179.62 Million | 276.7 Million | 69.92 Million | 53.77 Million | 78.97 Million | 79.8 Million |
| Depreciation & Amortization | 74.21 Million | 78.29 Million | 78.35 Million | 70.45 Million | 53.77 Million | 44.09 Million |
| Deferred income taxes | -10.77 Million | 7.9 Million | 2.33 Million | 477.63 Thousand | -1.13 Million | -966.57 Thousand |
| Stock-based compensation | 18.23 Million | 12.18 Million | - | -120 Thousand | 6.88 Million | - |
| Change in working capital | -201.25 Million | 67.4 Million | -19.41 Million | 52.67 Million | 8.11 Million | 31.73 Million |
| Other non-cash items | 19.27 Million | -140.87 Million | 56.75 Million | 59.4 Million | 15.96 Million | 20.42 Million |
| Investing Cash Flow | -197.4 Million | -301.49 Million | -230.02 Million | -174.14 Million | -347.61 Million | -58.83 Million |
| Investments in PPE | -218.77 Million | -171.24 Million | -184.71 Million | -167.76 Million | -199.44 Million | -74.89 Million |
| Acquisitions | -12.76 Million | -31.94 Million | -94.2 Million | 37.55 Thousand | 6.42 Million | -11.2 Million |
| Investment purchases | -152.41 Million | -351.04 Million | -283.29 Million | -150.83 Million | -216.55 Million | -29.13 Million |
| Sales/Maturities of investments | 159.25 Million | 253.24 Million | 197.07 Million | 142.49 Million | 160.33 Million | 149.42 Thousand |
| Other Investing Activities | 5.32 Million | -507.44 Thousand | 135.1 Million | 1.92 Million | -98.36 Million | 56.26 Million |
| Financing Cash Flow | -91.54 Million | 126.58 Million | -14.12 Million | 101.23 Million | 19.54 Million | 60.53 Million |
| Debt repayment | -117.48 Million | -686.94 Million | -490.33 Million | -326.39 Million | -180 Million | -66.28 Million |
| Dividends payments | -153.85 Million | -103.95 Million | -25.76 Million | -51.4 Million | -12.93 Million | -9.62 Million |
| Common Stock Repurchased | -1.89 Million | -2.62 Million | - | - | -26.28 Million | - |
| Common Stock Issuance | - | 2.62 Million | - | - | 28.02 Million | -18.61 Million |
| Other Financing Activities | -29.25 Million | 937.21 Million | 523.02 Million | 496.17 Million | 223.56 Million | 136.44 Million |
| Accounts receivables | -78.92 Million | 196.45 Million | -62.46 Million | -26.47 Million | -2.61 Million | -59.83 Million |
| Accounts payables | -86.56 Million | -90.28 Million | 87.4 Million | 82.68 Million | 14.89 Million | 113.64 Million |
| Inventory | -24.98 Million | -46.67 Million | -46.68 Million | -4.01 Million | -3.03 Million | -21.11 Million |
| Other working capital | 18.23 Million | 7.9 Million | 2.33 Million | 477.63 Thousand | -1.13 Million | 52.85 Million |
| Cash at beginning of period | 383.44 Million | 256.72 Million | 315.25 Million | 151.51 Million | 317 Million | 139.24 Million |
| Cash at end of period | 182.03 Million | 383.44 Million | 256.72 Million | 315.25 Million | 151.51 Million | 317 Million |
| Capital Expenditure | -218.77 Million | -171.24 Million | -184.71 Million | -167.76 Million | -199.44 Million | -74.89 Million |
| Effect of forex changes on cash | 1.88 | -3.76 | 0.02 | -0.11 | - | 0.28 |
| Net cash flow / Change in cash | -201.41 Million | 126.71 Million | -58.53 Million | 163.74 Million | -165.49 Million | 177.76 Million |
| Free Cash Flow | -131.23 Million | 130.37 Million | 915.7 Thousand | 68.89 Million | -36.87 Million | 101.16 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 91.29 Million | 66.65 Million | 70.19 Million | 44.82 Million | 179.62 Million | 35.28 Million |
| Depreciation & Amortization | - | 20.57 Million | 20.57 Million | 21.48 Million | 74.21 Million | -35.81 Million |
| Deferred income taxes | - | - | - | - | -10.77 Million | -117 Million |
| Stock-based compensation | - | 2.82 Million | - | 18.23 Million | 18.23 Million | -13.65 Million |
| Change in working capital | - | -118.22 Million | - | -85.68 Million | -201.25 Million | 166.47 Million |
| Other non-cash items | -40.35 Million | -26.68 Million | -23.29 Million | 75.92 Million | 19.27 Million | 8.63 Million |
| Investing Cash Flow | 5.38 Million | -12.48 Million | -28.63 Million | -26.97 Million | -197.4 Million | -79.08 Million |
| Investments in PPE | -17.64 Million | -19.95 Million | -41.85 Million | -32.5 Million | -218.77 Million | -75.09 Million |
| Acquisitions | 22.64 Million | 237.75 Thousand | 1.22 Million | -15.52 Million | -12.76 Million | 463.17 Thousand |
| Investment purchases | -16.7 Million | -35 Million | -20 Million | -50.39 Million | -152.41 Million | -31.02 Million |
| Sales/Maturities of investments | 17.07 Million | 40.09 Million | 20 Million | 44.14 Million | 159.25 Million | 26.56 Million |
| Other Investing Activities | - | 7.47 Million | 12 Million | 5.32 Million | 5.32 Million | 1.35 |
| Financing Cash Flow | -59.36 Million | -74.9 Million | 49.52 Million | -53.91 Million | -91.54 Million | 34.67 Million |
| Debt repayment | -51.36 Million | -23.66 Million | -57.98 Million | -14.22 Million | -117.48 Million | -50 Million |
| Dividends payments | - | -100.32 Million | -5.25 Million | -153.85 Million | -153.85 Million | -36.91 Million |
| Common Stock Repurchased | 377.22 Thousand | -377.22 Thousand | - | -1.89 Million | -1.89 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.38 Million | 1.76 Million | -8.45 Million | -19.3 Million | -29.25 Million | 121.59 Million |
| Accounts receivables | - | -74.46 Million | - | -78.92 Million | -78.92 Million | 102.86 Million |
| Accounts payables | - | - | - | - | -86.56 Million | -13.65 Million |
| Inventory | - | -46.58 Million | - | -24.98 Million | -24.98 Million | 63.61 Million |
| Other working capital | - | 2.82 Million | - | 18.23 Million | 18.23 Million | 13.65 Million |
| Cash at beginning of period | 202.05 Million | 249.82 Million | 190.14 Million | 163.87 Million | 383.44 Million | 164.93 Million |
| Cash at end of period | 195.44 Million | 181.87 Million | 276.99 Million | 182.03 Million | 182.03 Million | 163.87 Million |
| Capital Expenditure | -17.64 Million | -19.95 Million | -41.85 Million | -32.5 Million | -218.77 Million | -75.09 Million |
| Effect of forex changes on cash | - | 2.00 | 19.05 Million | - | 1.88 | -567.75 Thousand |
| Net cash flow / Change in cash | -6.61 Million | -67.94 Million | 86.84 Million | 18.15 Million | -201.41 Million | -1.05 Million |
| Free Cash Flow | 33.3 Million | -565.72 Thousand | 5.04 Million | 66.76 Million | -131.23 Million | -31.17 Million |
ZCAR
BIMETAL
0434
HENGY
BYW6
TFFIF